PEG-MGF (Pegylated Mechano Growth Factor): A Laboratory Research Reference

PEG-MGF (pegylated mechano growth factor) is a pegylated form of mechano growth factor, a splice variant of insulin-like growth factor 1 (IGF-1). It is studied in laboratory research for its role in skeletal muscle growth and repair signalling in experimental models.

This page is a non-promotional scientific reference for researchers. It summarises the chemical identity, molecular characteristics, mechanism as described in the literature, research areas, and analytical testing of PEG-MGF. It does not provide dosing, therapeutic, or human-use guidance of any kind. PEG-MGF supplied by Bulk Aussie Peptides is for laboratory research purposes only.

What Is PEG-MGF?

Mechano growth factor (MGF) is a naturally occurring splice variant of IGF-1, designated IGF-1Ec in humans or IGF-1Eb in rodents. It is produced in skeletal muscle in response to mechanical load and is studied for its role in satellite-cell activation and local muscle repair. PEG-MGF is a pegylated derivative, in which polyethylene glycol is conjugated to the peptide to increase its molecular size and slow its clearance in experimental systems.

For background on how modified research peptides are produced and verified, see the synthetic peptides research guide.

Molecular Characteristics

• Classification: a pegylated derivative of mechano growth factor, an IGF-1 splice variant peptide.
• Modification: polyethylene glycol (PEG) conjugation that increases molecular mass and extends circulating duration.
• Molecular weight: the MGF peptide core is roughly 2,866 Da before pegylation; the PEG group adds a variable mass reflected in the measured value on a Certificate of Analysis.
• Physical form: supplied as a lyophilised (freeze-dried) powder, the standard presentation for research material.

How PEG-MGF Works

In laboratory models, mechano growth factor is associated with activation of the IGF-1 receptor and downstream signalling that supports satellite cell proliferation and local muscle repair. PEGylation does not change the core receptor interaction but extends the molecule’s circulating half-life in experimental systems, an effect used to study sustained versus transient signalling. Research findings in this area remain preclinical.

These observations describe receptor pharmacology in model systems and do not constitute a therapeutic use.

Areas of Scientific Research

• Muscle growth signalling: studies of MGF and its pegylated form in skeletal muscle repair models.
• Satellite cell biology: investigation of satellite-cell activation and proliferation.
• Pegylation effects: comparison of native MGF with PEG-MGF to study circulating duration and bioactivity.

These investigations are conducted in vitro or in approved animal research models under institutional oversight. They do not translate to approved human use.

Analytical Testing

• HPLC for purity assessment, reported as a percentage of total peak area.
• Mass spectrometry for identity confirmation, reflecting the pegylated mass profile.

Guidance on reading the resulting documents is available in the article on how to read a peptide Certificate of Analysis.

Storage and Handling

In a laboratory context, lyophilised PEG-MGF is typically stored in a freezer, protected from light and moisture, and handled according to the product-specific documentation. General guidance is covered in the peptide storage and stability reference.

Frequently Asked Questions

• What is PEG-MGF? PEG-MGF is a pegylated form of mechano growth factor, an IGF-1 splice variant.
• Why is PEG added? PEG conjugation increases molecular size and slows clearance in experimental systems.
• How does MGF relate to IGF-1? MGF is a splice variant of IGF-1 that is produced in muscle in response to mechanical load.
• What is PEG-MGF studied for? It is investigated in laboratory models for muscle repair signalling.
• How is PEG-MGF purity tested? By HPLC, with identity confirmed by mass spectrometry.

References

• Yang, S., Alnaqeeb, M., Simpson, H., & Goldspink, G. (1996). Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. Journal of Muscle Research and Cell Motility, 17(4), 487–495. PubMed 8884603

Related Research Resources

• IGF-1 LR3: A Laboratory Research Reference — a related IGF-1 analogue.
• Synthetic Peptides: Research Guide — how research peptides are produced and verified.